Descrição

Subgroup analysis of sodium butyrate effectiveness in pediatric inflammatory bowel disease stratifies outcomes by disease type (Crohn's disease versus ulcerative colitis).

Figure 4

Chart

Source Paper

Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases-Randomized Placebo-Controlled Multicenter Trial.

Nutrients (2022)

PMID: 36014789

DOI: 10.3390/nu14163283

Cite This Figure

![Figure 4: Subgroup analysis of sodium butyrate effectiveness in pediatric inflammatory bowel disease stratifies outcomes by disease type (Crohn's disease versus ulcerative colitis).]()

> Source: Anna Pietrzak et al. "Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed I." *Nutrients*, 2022. PMID: [36014789](https://pubmed.ncbi.nlm.nih.gov/36014789/)

<figure>
  <img src="" alt="Subgroup analysis of sodium butyrate effectiveness in pediatric inflammatory bowel disease stratifies outcomes by disease type (Crohn's disease versus ulcerative colitis)." />
  <figcaption>Figure 4. Subgroup analysis of sodium butyrate effectiveness in pediatric inflammatory bowel disease stratifies outcomes by disease type (Crohn's disease versus ulcerative colitis).<br>  Source: Anna Pietrzak et al. "Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed I." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36014789/">36014789</a></figcaption>
</figure>

Evidências Relacionadas

Butyrate (Sodium/Calcium Butyrate) para Ulcerative Colitis (UC)

Nota C · 3 estudos

Butyrate (Sodium/Calcium Butyrate) para Crohn's Disease

Nota C · 2 estudos